Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Atrial Fibrillation, Atrial Myopathy and Thromboembolism: The Additive Value of Echocardiography and Possible New Horizons for Risk Stratification

Version 1 : Received: 16 April 2024 / Approved: 17 April 2024 / Online: 17 April 2024 (09:26:00 CEST)

How to cite: Campora, A.; Lisi, M.; Pastore, M.C.; Mandoli, G.E.; Ferrari Chen, Y.F.; Pasquini, A.; Rubboli, A.; Henein, M.; Cameli, M. Atrial Fibrillation, Atrial Myopathy and Thromboembolism: The Additive Value of Echocardiography and Possible New Horizons for Risk Stratification. Preprints 2024, 2024041134. https://doi.org/10.20944/preprints202404.1134.v1 Campora, A.; Lisi, M.; Pastore, M.C.; Mandoli, G.E.; Ferrari Chen, Y.F.; Pasquini, A.; Rubboli, A.; Henein, M.; Cameli, M. Atrial Fibrillation, Atrial Myopathy and Thromboembolism: The Additive Value of Echocardiography and Possible New Horizons for Risk Stratification. Preprints 2024, 2024041134. https://doi.org/10.20944/preprints202404.1134.v1

Abstract

This article explores the emerging concept of atrial myopathy (AM) and its potential role as a risk factor for stroke and dementia, both independently and in association with atrial fibrillation (AF). AM refers to structural and functional abnormalities of the atria, potentially causing blood clots formation and their subsequent embolization even in patients without AF. Echocardiography, particularly Left Atrial (LA) strain analysis, is a promising non-invasive tool for AM evaluation and might offer additional risk stratification beyond the established CHADS2-VASc score, potentially impacting anticoagulation decisions. By understanding AM and utilizing advanced imaging techniques like LA strain, clinicians can achieve a more comprehensive understanding of thromboembolic risk in specific patient groups. Integrating LA strain analysis into routine clinical practice holds promise for improved patient management and targeted therapies, allowing for better risk stratification in AF patients. However, standardized definitions and diagnostic criteria for AM are essential for consistent evaluation and research. Further studies are needed to explore the efficacy and safety of anticoagulation in AM patients without AF.

Keywords

Atrial fibrillation; Atrial myopathy; left atrial strain

Subject

Medicine and Pharmacology, Cardiac and Cardiovascular Systems

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.